OL-108

· Beijing GoBroad Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OL-108, covering 2025-05-20 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases [Phase 1]